IL13 and COVID-19: The successful and rapid identificationof IL-13-inducing epitopes using DeepEpilL13 paves the way for noveltherapeutic interventions against a range of conditions, includingallergic diseases, inflammatory conditions, and severe viral infectionssuch as COVID-19, with potential for a significant impact on publichealth outcomes.